Cancer Research
Research on cancer research discussed by scientists at University Hospital
Published in Cancer Weekly, August 31st, 2010
Investigators publish new data in the report 'Cyclin H expression is increased in GIST with very-high risk of malignancy.' According to a study from Ulm, Germany, "Risk estimation of gastrointestinal stromal tumours (GIST) is based on tumor size and mitotic rate according to the National Institutes of Health consensus classification. The indication for adjuvant treatment of patients with high risk GIST after R0 resection with small molecule inhibitors is still a controversial issue, since these patients represent a highly heterogeneous population."
"Therefore, additional prognostic indicators are needed. Here, we evaluated the prognostic value of cyclin H expression in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2010-08-31)
More Articles from Cancer Weekly
- Breast Cancer
Athena's Cup Surpasses 25,000 Bras and $30,000 in Donations to Support Breast Cancer Charities - Small Cell Lung Cancer
Data from Harvard University, Medical Department advance knowledge in small cell lung cancer - Gastric Cancer
Data from Sun Yat-Sen University, Cancer Center provide new insights into gastric cancer - Pancreatic Cancer
Data from Tokyo Metropolitan Komagome Hospital, Department of Internal Medicine provide new insights into pancreatic cancer - Apoptosis
Data from Tsinghua University advance knowledge in apoptosis - Colon Cancer
Data from University Medical Center provide new insights into colon cancer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
